RESEARCHERS
 
LOG IN
SIGN-UP
SEARCH
JUMP TO ADVANCED SEARCH
                                            
Dr. Goodyer's research laboratory at the MUHC Research Institute focuses on molecular control of kidney development as it pertains to hereditary renal disease
Welcome to the Genomics Sector Innovation Network (G-SIN) portal

Dr. Goodyer's research laboratory at the MUHC Research Institute focuses on molecular control of kidney development as it pertains to hereditary renal disease
EXPLORE >   Researchers >  Paul Goodyer
Paul Goodyer
RESEARCH
BIOGRAPHY
KEY PUBLICATIONS
INTELLECTUAL PROPERTY
Research

Dr. Goodyer reseach include molecular regulation of kidney development, PAX2 expression in renal cancer, diabetic nephropathy, maternal vitamin A deficiency and renal hypoplasia, hemolytic-uremic syndrome, PAX2 in polycystic kidney disease

Cell therapy of cystinosis
http://www.genomequebec.com/v2009/programmesRecherche/detailProjet.asp?id=g4p15&l=e

Researcher Information
Pediatric
Website
Montreal Children's Hospital
2300 Tupper E222A
Montréal , Quebec
Canada H3H 1P3
Send a message
Log In to mark favourites


Biography

Dr. Paul Goodyer is professor of Pediatrics at McGill University and a Pediatric Nephrologist at the Montreal Children's Hospital where he directs the Renal-Genetics Clinic. He heads a research laboratory at the McGill University Health Center Research Institute focused on molecular control of kidney development as it pertains to hereditary renal disease. With Nicoletta Eliopoulos of the Jewish General Hospital and an international team of collaborators, he is engaged in an effort to develop stem cell therapy for cystinosis, a rare genetic disease that is particularly prevalent among French Canadians.

Researcher Information
Pediatric
Website
Montreal Children's Hospital
2300 Tupper E222A
Montréal , Quebec
Canada H3H 1P3


Key Publications
"Miller MM, Iglesias DM, Zhang Z, Corsini R, Chu L, Murawski I, Gupta I, Somlo S, Germino GG, Goodyer PR.
T-cell factor/â-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.
Kidney Int. 2011 Jul;80(2):146-53. doi: 10.1038/ki.2011.56. "
"Zhang Z, Iglesias D, Eliopoulos N, El Kares R, Chu L, Romagnani P, Goodyer P.
A variant OSR1 allele which disturbs OSR1 mRNA expression in renal progenitor cells is associated with reduction of newborn kidney size and functionHum Mol Genet. 2011 Nov 1;20(21):4167-74"
"Zhang Z, Pascuet E, Hueber PA, Chu L, Bichet DG, Lee TC, Threadgill DW, Goodyer P.
Targeted inactivation of EGF receptor inhibits renal collecting duct development and function.
J Am Soc Nephrol. 2010 Apr;21(4):573-8. "
"Miller MM, Iglesias DM, Zhang Z, Corsini R, Chu L, Murawski I, Gupta I, Somlo S, Germino GG, Goodyer PR.
T-cell factor/â-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.
Kidney Int. 2011 Jul;80(2):146-53. doi: 10.1038/ki.2011.56. "
"Zhang Z, Iglesias D, Eliopoulos N, El Kares R, Chu L, Romagnani P, Goodyer P.
A variant OSR1 allele which disturbs OSR1 mRNA expression in renal progenitor cells is associated with reduction of newborn kidney size and functionHum Mol Genet. 2011 Nov 1;20(21):4167-74"
Researcher Information
Pediatric
Website
Montreal Children's Hospital
2300 Tupper E222A
Montréal , Quebec
Canada H3H 1P3


Intellectual Property

Researcher Information
Pediatric
Website
Montreal Children's Hospital
2300 Tupper E222A
Montréal , Quebec
Canada H3H 1P3
YOU MAY ALSO BE INTERESTED IN:


CATEGORIES
Application Area
Human health
Disciplinary Focus
Clinical science
Research Paradigm
Focused-scope projects
Core Technology
Nucleic acids: Genotyping
Organism
Human
Sign-up to edit this profile
Events Jobs What is Genomics Genomics in Canada About Us Contact Us Privacy Policy Terms of Use Site-Map
© Ontario Genomics Institute, 2007-2014.